trending Market Intelligence /marketintelligence/en/news-insights/trending/jv8j2twes3tastt80s4a4q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Edge Therapeutics gets Nasdaq noncompliance notice

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Edge Therapeutics gets Nasdaq noncompliance notice

Edge Therapeutics Inc. received a notice of noncompliance from Nasdaq for failing to meet the stock exchange's minimum $1 bid price listing standard.

The exchange granted Edge Therapeutics 180 calendar days, or until March 4, 2019, to regain compliance with the rule.

The Berkeley Heights, N.J.-based biotechnology said the notice has no immediate effect on its common stock which trades under the EDGE symbol on the Nasdaq Global Select Market.